ARTICLE | Company News
Achillion management update
October 25, 2010 7:00 AM UTC
Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Promoted: Milind Deshpande to president of R&D from EVP of R&D, while remaining CSO; Mary Fenton to SVP from VP, whi...